Could there possibly be an alternative way to protect ourselves from Covid without having to rely on dangerous, untested and not fully understood vaccines? Well, there could well be, they are being studied now! "Losartan," Solnatide, Avipdadil, and Dipeptidase.

Image Credit: Sonis Photography / Shutterstock.com

Yesterday, I stumbled onto a YouTube video from a very interesting man, Jerry Kroth, Ph.D. Now Mr. Jerry Kroth, Ph.D., just may have found an incredible defense against Covid-19 without having to have the vaccine, which would be absolutely incredible. However, there are two caveats that come with his information which will send alarm bells ringing in many heads who read this post further. One of the caveats is he has discovered his information from a "crop-circle?" So, for the people who have now stayed and are going to read on let me tell you I have posted Jerry's ground-breaking video below.

Ok, here we go, most of this stuff is way over my head: The Covid virus consists of spike proteins. Inside these spike proteins is something called SP8, which was also found in the Sars virus and had a "positive" immunological function. It now turns out that the SP8 epitope found in the Covid spike protein does indeed have a "positive" immunological function just as the Sars virus. It has a name too, (VLNDILSRL) and is located at positions, 958-966, which means nothing to me but I have added the info anyway. So according to Jerry, the Sars spike glycoprotein is fully present in the Covid spike glycoprotein sequence too.

What does the 8 stand for in SP8 found inside the spike protein? According to the experts, the 8 stands for Amino Acids, which make peptides that make protein. Now, this is where the video becomes very interesting. Peptides are being studied to target the virus in the US and Europe. These "peptides" are, "Losartan," Solnatide, Avipdadil, and something else called Dipeptidase.

I take "Losartan," for a heart condition and I have a very bad lung problem too and because of medication, my immune system is almost non-existent, since Covid broke in 2020 I have had pneumonia and several severe lung infections but no Covid, thank Goodness, I am now looking into the Losartan connection thanks to Jerry Kroth's video and have come up with some surprising results on Google search. Below is just a couple of finds...

Angiotensin receptor blockers (ARBs) and COVID-19

The downregulation of angiotensin-converting enzyme 2 (ACE2) has been shown to cause local RAS dysregulation. This can subsequently lead to pro-inflammatory, pro-apoptotic, and pro-thrombotic effects and, ultimately, COVID-19-induced cytokine storm.

Scientists have hypothesized that selective AT1R antagonism by angiotensin receptor blockers (ARBs) can aid in reducing COVID-19-related lung pathology. ARBs achieve this by rebalancing the Ang II/angiotensin (1-7) ratio and by indirectly promoting Ang II-induced activation of AT2R.

Recent studies have found that C21, which is an antagonist of AT2R, improved respiratory function in the hospitalization and mortality rates of COVID-19 patients. Notably, during the initial phases of the pandemic, the use of ARBs was limited owing to concerns over their possibility to increase its viral load, due to ACE2 upregulating effects. Further research has since proven that this is not the case and experimental and clinical studies on ARBs in COVID-19 are well underway.

In recent in silico studies, Losartan, which is an ARB, was shown to change the structure of ACE2, thereby affecting its binding with the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Losartan was also found to reduce inflammatory responses that would otherwise lead to acute respiratory distress and change the atomic configuration of SARS-CoV-2 PLpro.

The new study

In the current study, scientists examined the ability of Losartan to inhibit the deubiquitinase and deISGylase properties of SARS-CoV-2 PLpro. The authors also examined whether Losartan was capable of preventing viral replication in pre-and post-infected Vero E6 cells.

Losartan was first incubated at various concentrations with SARS-CoV-2 PLpro and a peptide substrate, which contained interferon-stimulated gene product 15 (ISG15). The results of this experiment suggested that Losartan could be interacting with certain elements of PLpro that are capable of accommodating peptide and Ub-like substrates. The inhibition rate of Losartan was 2.3% when tested against Ub-AMC and 6.9% against ISG15 cleavage. More here

Coronavirus Treatment: Losartan Might Help Us Combat COVID-19 Symptoms

Experts worldwide are experimenting with drugs to treat COVID-19. Those at the University of Minnesota have been testing if the blood pressure medication Losartan can prevent coronavirus infection or reduce the symptoms.

Since there isn’t a potential vaccine or treatment yet for the highly contagious respiratory illness, patients have to only rely on supportive care for now.

The generic blood pressure medication might ultimately help doctors fight back against the spread of COVID-19. The scientists are trying to determine whether Losartan can prevent severe symptoms and perhaps even prevent the rapid multiplication of the virus within a patient’s body, Reuters reported.

Losartan, also available under the brand name ‘Cozaar,’ blocks a specific cell receptor that the coronavirus might exploit. Preventing the deadly virus from binding to cells could significantly alter the patient’s recovery time and can also help curb the spread of the pandemic. However, we need to ensure that the drug works this way, BGR mentioned.

By far, only those exhibiting symptoms have been tested and lockdowns and quarantines have been advised to even those who appear healthy. Without any information pertaining to who has or has not been infected, such measures aren’t really sufficient to prevent COVID-19 from wreaking havoc.

Therefore, scientists have been experimenting with new drugs such as the blood pressure Losartan and the malarial drug hydroxychloroquine to find out if they can help prevent infections or reduce recovery times. Trials, currently, are underway and we might get the results within weeks. More here

A potential protective role of losartan against coronavirus-induced lung damage: Cambridge University Paper

xx

This crop circle appeared three weeks ago. Prof Jerry Kroth attempts to decode it in consultation with a biologist, microbiologist, and virologist. The crop circle shows appears to show the virus at a magnification of 12 million and features an enlarged spike protein magnified 100x greater than that. The elongated spike protein displays either 8 amino acids or a peptide which microbiologists refer to as “Sp8” in the scientific literature. This is a spike protein found in SARS which has an unusual positive immunological function, and it may have that function in Covid-19 as well. In other words, the crop circle appears to be proactively suggesting remedies and appears one step ahead of contemporary science.  The body of the virus displays 3 small circles likely the three letters of RNA, while the larger 3 circles may represent nonstructural proteins (NSP) This may be an extraterrestrial communication, although that it may have been created by human circle makers is also discussed. Prof. Kroth has made this white paper available for other crop circle scholars (and intrepid scientists) in hopes they will further decode this amazing structure and expand the knowledge base while this global pandemic is raging. To buy the book directly from Amazon go to https://www.amazon.com/dp/B08BZWBZRQ/... For more information, to contact Dr. Kroth, or to buy the book go to collectivepsych.com [Note Youtube censored a piece of this presentation about spike proteins, but I think you can still understand the talk without it—a copyright fair-use issue it seems and I lost that battle.] Flash: for those who have already watched the video, you may be interested to know a chief scientist for Novavax, who wrote to me and acknowledged that their vaccine under development is targeting Sp8!

Thank you Jerry for your wonderful video.

Coronavirus 2021

Front Page